Citations

Showing 10 of 108152 citations.

Potential use of electrohysterography in obstetrics: a review article
Huber, Carola , Shazly, Sherif A. , Ruano, Rodrigo

Mayo Clinic

The Journal of Maternal-Fetal & Neonatal Medicine | July 15, 2019 | Volume: 34 | Issue: 10 | Pages: 1666-1672

10.1080/14767058.2019.1639663 | PMID 31303075 Get It

Pathologic Hip Fracture Demonstrated on Ultrasound
Johnson, Shelby E. , Winemiller, Mark H.

Mayo Clinic

PM&R | July 15, 2019 | Volume: 12 | Issue: 2 | Pages: 219-220

10.1002/pmrj.12219 | PMID 31304672 Get It

Warfarin-Induced Rapid Rise in INR Post–Cardiac Surgery Is Not Associated With Increased Bleeding Risk
Olson, Logan M. , Nei, Andrea M. , Dierkhising, Ross , Joyce, David L. , Nei, Scott D. , Dierkhising, Ross A

Mayo Clinic

Annals of Pharmacotherapy | July 15, 2019 | Volume: 53 | Issue: 12 | Pages: 1184-1191

10.1177/1060028019858677 | PMID 31304766 Get It

Background: Post–cardiac surgery bleeding can have devastating consequences, and it is unknown if warfarin-induced rapid international normalized ratio (INR) rise during the immediate postoperative period increases bleed risk. Objective: To determine the impact of warfarin-induced rapid-rise INR on post–cardiac surgery bleeding. Methods: This was a single-center, retrospective chart review of post–cardiac surgery patients initiated on warfarin at Mayo Clinic Hospital, Rochester. Patients were grouped based on occurrence or absence of rapid-rise INR (increase ≥1.0 within 24 hours). The primary outcome compared bleed events between groups. Secondary outcomes assessed hospital length of stay (LOS) and identified risk factors associated with bleed events and rapid rise in INR. Results: During the study period, 2342 patients were included, and 56 bleed events were evaluated. Bleed events were similar between rapid-rise (n = 752) and non–rapid-rise (n = 1590) groups in both univariate (hazard ratio [HR] = 1.22; P = 0.594) and multivariable models (HR = 1.24; P = 0.561). Those with rapid-rise INR had longer LOS after warfarin administration (discharge HR = 0.84; P = 0.0002). The most common warfarin dose immediately prior to rapid rise was 5 mg. Risk factors for rapid-rise INR were low body mass index, female gender, and cross-clamp time. Conclusion and Relevance: This represents the first report to assess warfarin-related rapid-rise INR in post–cardiac surgery patients and found correlation to hospital LOS but not bleed events. Conservative warfarin dosing may be warranted until further research can be conducted.
Aortic valve replacement-induced changes in native T1 are related to prognosis in severe aortic stenosis: T1 mapping cardiac magnetic resonance imaging study
Kim, Hyung‐Kwan , Park, Jun‐Bean , Park, Eun‐Ah , Lee, Seung‐Pyo , Kim, Yong-Jin , Oh, Jae K. , Kim, Hyung-Kwan , Hwang, In‐Chang , Lee, Whal , Sohn, Daewon

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | July 13, 2019 | Volume: 21 | Issue: 6 | Pages: 653-663

10.1093/ehjci/jez201 | PMID 31377777 Get It

Abstract Aims Native T1 times from T1 mapping cardiac magnetic resonance (CMR) are associated with myocardial fibrosis in aortic stenosis (AS). We investigated whether changing patterns in native T1 predict clinical outcomes after aortic valve replacement (AVR) in severe AS patients. Methods and results Forty-three patients with severe AS (65.9 ± 8.1 years; 24 men) who underwent T1 mapping CMR at baseline and 1 year after AVR were prospectively enrolled. Upper limit of native T1 from healthy volunteers was used to define normal myocardium and diffuse fibrosis (native T1 < 1208.4 and ≥1208.4 ms, respectively). Participants were categorized into Group 1 (pre- and post-AVR normal myocardium; n = 11), Group 2 (pre-AVR diffuse fibrosis and post-AVR normal myocardium; n = 18), and Group 3 (post-AVR diffuse fibrosis; n = 14). Native T1 significantly decreased 1 year after AVR (pre-AVR, 1233.8 ± 49.7 ms; post-AVR, 1189.1 ± 58.4 ms; P < 0.001), which was associated with left ventricular (LV) mass regression (△native T1 vs. △LV mass index, r = 0.454, P = 0.010) and systolic function improvement (△native T1 vs. △LV ejection fraction, r = −0.379, P = 0.012). Group 2 showed greater functional improvements, whereas these benefits were blunted in Group 3. Group 3 had significantly worse outcomes than Group 1 [hazard ratio (HR), 9.479, 95% confidence interval (CI) 1.176–76.409; P = 0.035] and Group 2 (HR 3.551, 95% CI 1.178–10.704; P = 0.024). Conclusion AVR-induced changes in native T1 values are associated with LV systolic functional changes as well as prognosis in severe AS. Post-AVR T1 mapping CMR can be used as an imaging biomarker.
Depression Outcomes in Smokers and Nonsmokers: Comparison of Collaborative Care Management Versus Usual Care
Akambase, Joseph , Garrison, Gregory M. , Stadem, Paul, Talley, Heather Laine, Angstman, Kurt B. , Akambase, Joseph A , Miller, Nathaniel E. , Garrison, Gregory M , Talley, Heather, Angstman, Kurt B , Talley, Heather

Mayo Clinic

Journal of Primary Care & Community Health | July 13, 2019 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2150132719861265 | PMID 31303098 Get It

Background: Depression is common in the primary care setting and tobacco use is more prevalent among individuals with depression. Recent research has linked smoking to poorer outcomes of depression treatment. We hypothesized that in adult primary care patients with the diagnosis of depression, current smoking would have a negative impact on clinical outcomes, regardless of treatment type (usual primary care [UC] vs collaborative care management [CCM]). Methods: A retrospective chart review study of 5155 adult primary care patients with depression in a primary care practice in southeast Minnesota was completed. Variables obtained included age, gender, marital status, race, smoking status, initial Patient Health Questionnaire–9 (PHQ-9), and 6-month PHQ-9. Clinical remission (CR) was defined as 6-month PHQ-9 <5. Persistent depressive symptoms (PDS) were defined as PHQ-9 ≥10 at 6 months. Treatment in both CCM and UC were compared. Results: Using intention to treat analysis, depressed smokers treated with CCM were 4.60 times as likely (95% CI 3.24-6.52, P < .001) to reach CR and were significantly less likely to have PDS at 6 months (adjusted odds ratio [AOR] 0.19, 95% CI 0.14-0.25, P < .001) compared with smokers in UC. After a 6-month follow-up, depressed smokers treated with CCM were 1.75 times as likely (95% CI 1.18-2.59, P = .006) to reach CR and were significantly less likely to have PDS (AOR 0.45, 95% CI 0.31-0.64, P < .001) compared with smokers in UC. Conclusions: CCM significantly improved depression outcomes for smokers at 6 months compared with UC. However, in the UC group, smoking outcomes were not statistically different at 6 months for either remission or PDS. Also, nonsmokers in CCM had the best clinical outcomes at 6 months in both achieving clinical remission and reduction of PDS when compared with smokers in UC as the reference group.
A 360° electronic device for recording high-resolution intraoperative electrocorticography of the brain during awake craniotomy
ReFaey, Karim , Chaichana, Kaisorn L. , Vivas-Buitrago, Tito , Brinkmann, Benjamin H. , Middlebrooks, Erik H. , McKay, Jake H., Lankford, David J., Tripathi, Shashwat , Bojaxhi, Elird , Roth, Grayson, Tatum, William O. , Quiñones‐Hinojosa, Alfredo , Feyissa, Anteneh M. , Roth, Grayson E, Brinkmann, Benjamin H , Middlebrooks, Erik H , ReFaey, Karim

Mayo Clinic

Journal of Neurosurgery | July 13, 2019 | Volume: 133 | Issue: 2 | Pages: 443-450

10.3171/2019.4.jns19261 | PMID 31277069 Get It

OBJECTIVEEpilepsy is common among patients with supratentorial brain tumors; approximately 40%–70% of patients with glioma develop brain tumor–related epilepsy (BTRE). Intraoperative localization of the epileptogenic zone during surgical tumor resection (real-time data) may improve intervention techniques in patients with lesional epilepsy, including BTRE. Accurate localization of the epileptogenic signals requires electrodes with high-density spatial organization that must be placed on the cortical surface during surgery. The authors investigated a 360° high-density ring-shaped cortical electrode assembly device, called the “circular grid,” that allows for simultaneous tumor resection and real-time electrophysiology data recording from the brain surface.METHODSThe authors collected data from 99 patients who underwent awake craniotomy from January 2008 to December 2018 (29 patients with the circular grid and 70 patients with strip electrodes), of whom 50 patients were matched-pair analyzed (25 patients with the circular grid and 25 patients with strip electrodes). Multiple variables were then retrospectively assessed to determine if utilization of this device provides more accurate real-time data and improves patient outcomes.RESULTSMatched-pair analysis showed higher extent of resection (p = 0.03) and a shorter transient motor recovery period during the hospitalization course (by approximately 6.6 days, p ≤ 0.05) in the circular grid patients. Postoperative versus preoperative Karnofsky Performance Scale (KPS) score difference/drop was greater for the strip electrode patients (p = 0.007). No significant difference in postoperative seizures between the 2 groups was present (p = 0.80).CONCLUSIONSThe circular grid is a safe, feasible tool that grants direct access to the cortical surgical surface for tissue resection while simultaneously monitoring electrical activity. Application of the circular grid to different brain pathologies may improve intraoperative epileptogenic detection accuracy and functional outcomes, while decreasing postoperative complications.
Impact of cochlear modiolus dose on hearing preservation following stereotactic radiosurgery for non–vestibular schwannoma neoplasms of the lateral skull base: a cohort study
Jacob, Jeffrey T. , Graffeo, Christopher S. , Perry, Avital , Oldenburg, Michael , Foote, Robert L. , Pollock, Bruce E. , Driscoll, Colin L. W., Carlson, Matthew L. , Link, Michael J. , Carlstrom, Lucas P.

Mayo Clinic

Journal of Neurosurgery | July 13, 2019 | Volume: 133 | Issue: 3 | Pages: 736-741

10.3171/2019.4.jns19201 | PMID 31299651 Get It

OBJECTIVERadiation dose to the cochlea has been proposed as a key prognostic factor in hearing preservation following stereotactic radiosurgery (SRS) for vestibular schwannoma (VS). However, understanding of the predictive value of cochlear dose on hearing outcomes following SRS for patients with non-VS tumors of the lateral skull base (LSB) is incomplete. The authors investigated rates of hearing loss following high-dose SRS in patients with LSB non-VS lesions compared with patients with VS.METHODSPatients with LSB meningioma or jugular paraganglioma and serviceable pretreatment hearing who underwent SRS treatment during 2007–2016 and received a modiolus dose > 5 Gy were included in a retrospective cohort study, along with a similarly identified control group of consecutive patients with sporadic VS.RESULTSSixteen patients with non-VS tumors and a control group of 43 patients with VS met study criteria. Serviceable hearing, defined as American Academy of Otololaryngology–Head and Neck Surgery class A/B, was maintained in 13 non-VS versus 23 VS patients (81% vs 56%, p = 0.07). All 3 instances of hearing loss in non-VS patients were observed in cerebellopontine angle (CPA) meningiomas. Non-VS with preserved hearing had a median modiolus dose of 6.9 Gy (range 5.7–19.2 Gy), versus 7.4 Gy (range 5.4–7.6 Gy) in those patients with post-SRS hearing loss (p = 0.53). Sporadic VS patients received an overall median modiolus point-dose of 6.8 Gy (range 5.4–11.7 Gy).CONCLUSIONSThe modiolus dose threshold of 5 Gy does not predict hearing loss in patients with non-VS tumors undergoing SRS, suggesting that dosimetric parameters derived from VS may not be applicable to this population. Differential rates of hearing loss appear to vary by pathology, with paragangliomas and petroclival meningiomas demonstrating decreased risk of hearing loss compared to CPA meningiomas that may directly compress the cochlear nerve similarly to VS.
Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study
Hedayati, Elham , Papakonstantinou, Andri , Gernaat, Sofie A. M. , Altena, Renske , Brand, Judith S. , Alfredsson, Joakim , Herrmann, J., Linde, Cecilia , Dahlström, Ulf , Bergh, Jonas , Hűbbert, Laila , Herrmann, Jeorg, Bhoo‐Pathy, Nirmala

Mayo Clinic

European Heart Journal - Quality of Care and Clinical Outcomes | July 12, 2019 | Volume: 6 | Issue: 2 | Pages: 147-155

10.1093/ehjqcco/qcz039 | PMID 31328233 Get It

AbstractAimsHeart failure (HF) patients diagnosed with breast cancer (BC) may have a higher risk of death, and different HF presentation and treatment than patients without BC.Methods and resultsA total of 14 998 women with incident HF (iHF) or prevalent HF (pHF) enrolled in the Swedish HF Registry within and after 1 month since HF diagnosis, respectively, between 2008 and 2013. Patients were linked with the National Patient-, Cancer-, and Cause-of-Death Registry. Two hundred and ninety-four iHF and 338 pHF patients with BC were age-matched to 1470 iHF and 1690 pHF patients without BC. Comorbidity and treatment characteristics were compared using the χ2 tests for categories. Cox proportional hazard models assessed the hazard ratio (HR) and 95% confidence intervals (95% CIs) of all-cause and cardiovascular mortality among HF patients with and without BC. In the pHF group, BC patients had less often myocardial infarction (21.6% vs. 28.6%, P &lt; 0.01) and received less often aspirin (47.6% vs. 55.1%, P = 0.01), coronary revascularization (11.8% vs. 16.2%, P &lt; 0.01), or device therapy (0.9% vs. 3.0%, P = 0.03). After median follow-up of 2 years, risk of all-cause mortality (iHF: HR = 1.04, 95% CI = 0.83–1.29 and pHF: HR = 0.94, 95% CI = 0.79–1.12), cardiovascular mortality (iHF: HR = 0.94, 95% CI = 0.71–1.24 and pHF: HR = 0.89, 95% CI = 0.71–1.10), and HF mortality (iHF: HR = 0.80, 95% CI = 0.34–1.90 and pHF: HR = 0.75, 95% CI = 0.43–1.29) were similar for patients with and without BC in the iHF and pHF groups.ConclusionRisk of all-cause and cardiovascular mortality in HF patients did not differ by BC status. Differences in pre-existing myocardial infarction and HF treatment among pHF patients with and without BC may suggest differences in pathogenesis of HF.
The MYD88L265P conundrum in IgM monoclonal gammopathy of undetermined significance
Kapoor, Prashant

Mayo Clinic

British Journal of Haematology | July 12, 2019 | Volume: 187 | Issue: 4 | Pages: 413-415

10.1111/bjh.16085 | PMID 31298748 Get It